As of 2025-07-14, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 32.49 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.98 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 54.8%.
The range of the Relative Valuation is 22.99 - 42.59 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 24.2x | 22.8x |
| Forward P/E multiples | 15.1x - 23.6x | 18.7x |
| Fair Price | 22.99 - 42.59 | 32.49 |
| Upside | 9.6% - 103.0% | 54.8% |
| Date | P/E |
| 2025-07-14 | 15.32 |
| 2025-07-11 | 15.33 |
| 2025-07-10 | 16.12 |
| 2025-07-09 | 15.76 |
| 2025-07-08 | 15.36 |
| 2025-07-07 | 15.26 |
| 2025-07-03 | 15.31 |
| 2025-07-02 | 15.52 |
| 2025-07-01 | 15.61 |
| 2025-06-30 | 15.76 |
| 2025-06-27 | 16.17 |
| 2025-06-26 | 16.23 |
| 2025-06-25 | 16.44 |
| 2025-06-24 | 16.38 |
| 2025-06-23 | 16.43 |
| 2025-06-20 | 16.60 |
| 2025-06-18 | 16.77 |
| 2025-06-17 | 16.66 |
| 2025-06-16 | 16.18 |
| 2025-06-13 | 15.87 |
| 2025-06-12 | 15.89 |
| 2025-06-11 | 16.30 |
| 2025-06-10 | 16.22 |
| 2025-06-09 | 16.30 |
| 2025-06-06 | 16.06 |
| 2025-06-05 | 15.60 |
| 2025-06-04 | 15.91 |
| 2025-06-03 | 16.06 |
| 2025-06-02 | 15.69 |
| 2025-05-30 | 15.76 |
| 2025-05-29 | 16.29 |
| 2025-05-28 | 16.09 |
| 2025-05-27 | 16.22 |
| 2025-05-23 | 16.06 |
| 2025-05-22 | 15.75 |
| 2025-05-21 | 15.97 |
| 2025-05-20 | 15.85 |
| 2025-05-19 | 16.07 |
| 2025-05-16 | 16.27 |
| 2025-05-15 | 12.86 |
| 2025-05-14 | 12.54 |
| 2025-05-13 | 12.57 |
| 2025-05-12 | 12.80 |
| 2025-05-09 | 12.75 |
| 2025-05-08 | 12.37 |
| 2025-05-07 | 10.82 |
| 2025-05-06 | 10.63 |
| 2025-05-05 | 11.06 |
| 2025-05-02 | 10.90 |
| 2025-05-01 | 10.65 |